GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of what changed for me between month 11 and month 20 — 54 comments in the full submission. View in context.
2.4k
c/t2dglp1·submitted 1 year ago by u/osman_ferrari

what changed for me between month 11 and month 20

Questionbranch of 7 comments

The title is the whole question — what changed for me between month 11 and month 20 — but here is why I am asking. Certain conditions affect A1c independently of glycaemia. If a result looks inconsistent with the sensor data, that is a question for whoever manages your care rather than for this board. The diabetes…

Read the full submission and all 54 comments →

This branch

7 comments, started 1 year ago
u/britt_abubakar52 points·1 year ago

Postprandial excursions flattened out first and the fasting number took months to follow. Nobody had told me to expect that order.

replysharereportpermalink
[removed]38 points·1 year ago

[removed by moderator]

replysharereportpermalink
u/fasting_insulin_f21 points·1 year ago

postprandial excursions are where most of the improvement shows up first

replysharereportpermalink
u/marisol_moreau-14 points·1 year ago

nothing here replaces the person managing your diabetes

replysharereportpermalink
u/osman_ferrariOP1 point·1 year ago

My ApoB moved and it turned out to have nothing to do with glucose at all.

replysharereportpermalink
u/arne_nyberg1 point·1 year ago·edited

Small fix — insulin secretion in this class is glucose-dependent, which is precisely why the risk you describe comes from the other agent.

replysharereportpermalink
u/bianca_demir1 point·1 year ago

Same. The first day of a new sensor is unreliable and people rebuild their whole week around it.

replysharereportpermalink

← back to the whole thread

About c/t2dglp1

Type 2 diabetes as the original indication: A1c trajectories, CGM traces, hypoglycaemia risk when stacked with sulfonylureas or insulin, metformin combinations, and why the weight-loss conversation sometimes drowns out the glycaemic one.

36kmembers
62submissions
Jun 2024created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/t2dglp1 rules
  1. Insulin and sulfonylurea interactions are a real hypo risk. Do not hand-wave them.
  2. Post A1c with units and the assay date.
  3. No medication-stopping advice. Ever.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.